Loading...
Pentraxin-3 in patients with severe sepsis or shock: the ALBIOS trial
BACKGROUND: The long pentraxin PTX3 is a key component of the humoral arm of innate immunity related to sepsis severity and mortality. We evaluated the clinical and prognostic significance of circulating PTX3 in the largest cohort ever reported of patients with severe sepsis or septic shock. DESIGN:...
Na minha lista:
| Udgivet i: | Eur J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414835/ https://ncbi.nlm.nih.gov/pubmed/27864924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/eci.12704 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|